Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001140361-23-025558

SVP, CFO sold 7,918 shares at an average $2.04 ($16,131)

From the SEC's structured data for this filing

Trades in this filing

Hyllengren Eric J · SVP, CFO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-05-16 Sale : show line 1 in the form −6,199 $2.04 $12,627 227,861 D
2023-05-16 Sale : show line 2 in the form −1,719 $2.04 $3,503 226,142 D
Open-market sales · 7,918 sh · avg $2.04 · $16,131
Loading xslF345X04/form4.xml…